drugset / Trial / NCT02158585
Study of Lamotrigine to Treat Ménière's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This double-blinded study evaluates the frequency of vertigo attacks and the quality of life of patients diagnosed with Ménière's disease after being randomly assigned to take a placebo or lamotrigine.
Timeline
- Start
- 2014-06
- Primary completion
- 2017-03
- Completion
- 2017-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lamotrigine | Small molecule | 150 mg | Oral |